Advanced Enzyme Technologies Share Price

Advanced Enzyme

CMP as on 22-Oct-20 15:59

₹ 324.90
-6.75 -2.04%

Open

₹ 331.40

Turnover (lac)

₹ 466

Prev. Close

₹ 331.65

Day's Vol (shares)

₹ 1,43,524

Day's Range (₹)

₹ 324.00
₹ 333.45

CMP as on22-Oct-20 15:29

₹ 325.40
-5.8 -1.75%

Open

₹ 332.90

Turnover (lac)

₹ 17

Prev. Close

₹ 331.20

Day's Vol (shares)

₹ 8,579

Day's Range

₹ 324.00
₹ 333.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 04-Aug-2020 - -
Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2020 ,inter alia, to consider and approve This is to inform that the Meeting of Board of Directors of Company is scheduled to be held through video conference on Wednesday, 12th August 2020, inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2020. With reference to the Board meeting notice dated August 04, 2020, we hereby inform that the Board of Directors in its meeting held on August 12, 2020 (commenced at 11:00 a.m. and concluded at 11:35 a.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter ended June 30, 2020. In view of the aforesaid, we hereby enclose the following: Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2020 along with the Limited Review report issued by B S R & Co. LLP, Statutory Auditors of the Company as Annexure. Press Release and Earnings Presentation for the quarter ended June 30, 2020. The aforesaid financial results along with Limited Review Report, Press Release and Earnings Presentation are also being uploaded on the website of the Company, i.e. www.advancedenzymes.com This is for your information and for public at large. (As Per BSE Announcement Dated on 12.08.2020)
Board Meeting - 23-May-2020 - -
Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2020 ,inter alia, to consider and approve This is to inform you that the Meeting of Board of Directors of Company is scheduled to be held through video conference on Saturday, 30th May 2020, inter alia, to consider the following: Approval of Audited Financial Statements (Standalone & Consolidated) of the Company for the financial year ended March 31, 2020 along with results of the fourth quarter; Recommendation of the Final dividend, if any, for the financial year ended March 31, 2020. Closure of Trading Window: Further to our letter dated 30th March, 2020 intimating closure of Trading Window, we wish to inform you that for the above mentioned purpose, the Trading Window for dealing in the Securities of the Company will continue to remain close upto Monday, June 01, 2020. With reference to the notice of Board Meeting dated May 23, 2020, we hereby inform that the Board of Directors in its Meeting held on May 30, 2020 (commenced at 12:30 p.m. and concluded at 1:35 p.m.) has inter alia, transacted the following business: 1. Approved the Audited Financial Results (Standalone and Consolidated) of the Company for the financial year ended March 31, 2020 along with fourth quarter results. 2. Recommended a Dividend @ 30% i.e. Rs. 0.60/- per equity share on the face value of Rs. 2/- each for the financial year ended March 31, 2020, subject to the approval of the Shareholders at the ensuing 31st Annual General Meeting of the Company (AGM). The Dividend, if approved / declared by the Shareholders at 31st AGM, will be paid on and from the second (2nd) day from the date of AGM. Book Closure period for the entitlement of the Dividend and date & timings for ensuing Annual General Meeting of the Company shall be intimated in due course of time. (As Per BSE Announcement Dated on 30.05.2020)
Board Meeting - 28-Mar-2020 - -
The Board of Directors of the Company, on March 28, 2020, approved the appointment of Ms. Rajshree Patel (US Passport No. 488344413) as an Additional Director (Woman Independent Director), subject to and with effect from the date of allotment of Director Identification Number (DIN), once obtained by her, to hold office upto the date of ensuing Annual General Meeting of the Company (AGM) or the date upto which AGM shall be held whichever is earlier. Subject to the above and the approval of the shareholders at the ensuing AGM of the Company, Ms. Rajshree Patel to hold office as an Independent Director for a period of 3 (three) years effective from the date of allotment of DIN A brief profile of Mrs. Rajshree Patel is enclosed herewith as Annexure - I.
Board Meeting - 24-Jan-2020 - -
Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2020 ,inter alia, to consider and approve To consider and approve Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2019 With reference to the Board meeting notice dated January 24, 2020, we hereby inform that the Board of Directors in its meeting held on February 06, 2020 (commenced at 12.35 p.m. and concluded at 1.05 p.m.) has inter-alia, transacted the following business: 1. Approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and nine months ended December 31, 2019 2. Allotted 2,000 equity shares of face value of Rs. 2/- at an exercise price of Rs. 60 per share pursuant to exercise of options by the eligible employees under the Companys Employees Stock Option Scheme, 2015. With reference to the Board meeting notice dated January 24, 2020, we hereby inform that the Board of Directors in its meeting held on February 06, 2020 (commenced at 12.35 p.m. and concluded at 1.05 p.m.) has allotted 2,000 equity shares of face value of Rs. 2/- at an exercise price of Rs. 60 per share pursuant to exercise of options by the eligible employees under the Companys Employees Stock Option Scheme, 2015 (As Per BSE Announcement dated on 06/02/2020)
Board Meeting - 22-Oct-2019 - -
Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2019 ,inter alia, to consider and approve inter-alia, un-audited financial results for Second Quarter ended September 30, 2019. Board of Directors in its meeting held on November 02, 2019 (commenced at 11:20 a.m. and concluded at 12:15 p.m.) has inter-alia, transacted the following business: Approval of the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and half year ended September 30, 2019. appointment of Dr. Sunny Sharma (DIN: 02267273), as an Additional Director (Non-Executive) on the Board of the Company with immediate effect, to hold office upto the ensuing Annual General Meeting of the Company. Approved the discontinuation of operations & closure of wholly owned subsidiary of the Company in Malaysia, Advanced Enzymes (Malaysia) Sdn. Bhd. (AEM) and to initiate the process of closure thereto, since the company is not giving the desired results. Approval of the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and half year ended September 30, 2019. Unaudited Financial Results (Standalone & Consolidated) for the quarter ended September 30, 2019 along with the Limited Review report issued by B S R & Co. LLP, Statutory Auditors of the Company as Annexure - I. Earnings Presentation for the quarter and half year ended September 30, 2019. The Board in its meeting held on 2nd November 2019 has approved the appointment of Dr. Sunny Sharma (DIN: 02267273), as an Additional Director (Non-Executive) on the Board of the Company with immediate effect, to hold office upto the ensuing Annual General Meeting of the Company. A brief profile of Dr. Sunny Sharma is enclosed herewith as Annexure-II (As Per BSE Announcement Dated on 02.11.2019)